GlassScriptPhysician profile
Krishna C Gurram
NPI 1255360244
$5,342.75
in general payments reported to CMS, 2019-2025
9 companies · $1,536 in 2025
The $1,536 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $1,497 · 2021: $198 · 2022: $1,010 · 2023: $270 · 2024: $394 · 2025: $1,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,261 · Travel and Lodging: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.27 |
| Travel and Lodging | $938.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,318.50 | 2019-2025 | Apollo Esg Nxt System, Overstitch Nxt Endoscopic Suturing System, Habib Endohpb |
| Olympus Corporation of The Americas | $420.33 | 2020 | |
| Olympus America INC. | $220.46 | 2024-2025 | Endoclot Phs, Single Use Repositionable Clip, Endoclot Sis |
| Steris Corporation | $111.64 | 2024 | |
| Janssen Biotech, INC. | $100.30 | 2019 | |
| Abbvie INC. | $95.72 | 2020-2025 | |
| Gilead Sciences, INC. | $31.21 | 2025 | Livdelzi |
| Endogastric Solutions, INC | $24.13 | 2023 | Esophyx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.46 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Gurram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.